WSJ News Exclusive | Horizon Therapeutics Fields Takeover Interest From Pharma Giants

The drugmaker recently had a market value of about $18 billion as large pharmaceutical companies rely…

Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon

U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron,…

Latest Covid Boosters Are Set to Roll Out Before Human Testing Is Completed

The Food and Drug Administration is expected to authorize new Covid-19 booster shots this week without…

Moderna Sues Pfizer and BioNTech, Alleging Infringement of MRNA Patents

Moderna Inc. sued rival Covid-19 vaccine makers Pfizer Inc. and BioNTech SE, alleging that the companies’…

Pfizer, BioNTech Ask FDA to Green Light Tweaked Covid-19 Vaccine

This copy is for your personal, non-commercial use only. Distribution and use of this material are…

Biotech Rebounds on Optimism and Deal Making

Listen to article (2 minutes) Biotech stocks, some of the biggest losers in the selloff, are…

Wall Street Deal Making Faces Greater Scrutiny, Delays Under FTC’s Lina Khan

Listen to article (2 minutes) WASHINGTON—The Biden administration’s antitrust enforcers are throwing sand in the gears…

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Updated Aug. 8, 2022 7:11 am ET Pfizer Inc. has agreed to buy Global Blood Therapeutics…

WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved…

U.S. Would Gain Power to Negotiate Drug Prices Under Manchin-Schumer Bill

Listen to article (2 minutes) A deal between Senate Democrats has revived legislation to significantly expand…